Skip to content

Eton Pharmaceuticals, Inc. ETON Software and Technology Licenses, Net

Software and Technology Licenses, Net at other companies

Zevra Therapeutics, Inc. logo
Zevra Therapeutics, Inc.ZVRA
XER
Xeris Biopharma Holdings, Inc.XERS
Ultragenyx Pharmaceutical logo
Ultragenyx PharmaceuticalRARE
ANI Pharmaceuticals logo
ANI PharmaceuticalsANIP
Neurocrine Biosciences logo
Neurocrine BiosciencesNBIX
Travere Therapeutics, Inc. logo
Travere Therapeutics, Inc.TVTX

Other financials

Income statement

See full
Revenue$24.3M+40.4%
Gross profit$14.7M+49.4%
Operating income$2.4M+614%
Net income$1.6M+199%
EPS (diluted)$0.05+183%

Balance sheet

See full
Cash & equivalents$19.7M+12.9%
Total debt$31.3M+3.7%
Total equity$30.6M+25.2%
Total assets$97.7M+16.3%

Cash flow

See full
Operating cash flow$7.4M+254%
CapEx$75.0K
Free cash flow$7.3M+251%

Valuation

See full
Market cap$930.79M+156%
Enterprise value$942.39M+150%
P/S10.7×+3.2×

Profitability

See full
Gross margin54.8%-3.7pp
Operating margin-15.1%
Net margin-9.5%-2.7pp
FCF margin17.1%

Returns & leverage

See full
Return on equity-34.2%+0.9pp
Debt / equity-0.2×
Current ratio1.2×-0.8×

Where this comes from

Reported directly by Eton Pharmaceuticals, Inc. in its filing.

Tagged under the XBRL concept us-gaap:OtherAssetsNoncurrent.

The official record: Eton Pharmaceuticals, Inc.’s 10-Q, filed May 14, 2026, on SEC EDGAR. View the filing →

Ask your AI about Eton Pharmaceuticals, Inc.'s software and technology licenses, net.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Eton Pharmaceuticals, Inc.'s software and technology licenses, net?
Eton Pharmaceuticals, Inc. (ETON) reported software and technology licenses, net of $54K in Q1 2026.
How has Eton Pharmaceuticals, Inc.'s software and technology licenses, net changed year-over-year?
Eton Pharmaceuticals, Inc.'s software and technology licenses, net increased by 350.0% year-over-year, from $12K to $54K.
What is the long-term trend for Eton Pharmaceuticals, Inc.'s software and technology licenses, net?
Over 5 years (2020 to 2025), Eton Pharmaceuticals, Inc.'s software and technology licenses, net has grown at a -36.4% compound annual growth rate (CAGR), from $182K to $19K.